FR2372829A1 - Nouveaux derives imidazoliques, leur procede de preparation et leur application comme medicaments - Google Patents

Nouveaux derives imidazoliques, leur procede de preparation et leur application comme medicaments

Info

Publication number
FR2372829A1
FR2372829A1 FR7735727A FR7735727A FR2372829A1 FR 2372829 A1 FR2372829 A1 FR 2372829A1 FR 7735727 A FR7735727 A FR 7735727A FR 7735727 A FR7735727 A FR 7735727A FR 2372829 A1 FR2372829 A1 FR 2372829A1
Authority
FR
France
Prior art keywords
application
preparation process
new
medicinal products
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7735727A
Other languages
English (en)
Other versions
FR2372829B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2372829A1 publication Critical patent/FR2372829A1/fr
Application granted granted Critical
Publication of FR2372829B1 publication Critical patent/FR2372829B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/74—Naphthothiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nouveaux dérivés imidazoliques, leur procédé de préparation et leur application comme médicaments. Les composés de l'invention ont pour formule générale :
FR7735727A 1976-12-01 1977-11-28 Nouveaux derives imidazoliques, leur procede de preparation et leur application comme medicaments Granted FR2372829A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU76303 1976-12-01

Publications (2)

Publication Number Publication Date
FR2372829A1 true FR2372829A1 (fr) 1978-06-30
FR2372829B1 FR2372829B1 (fr) 1982-06-04

Family

ID=19728422

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7735727A Granted FR2372829A1 (fr) 1976-12-01 1977-11-28 Nouveaux derives imidazoliques, leur procede de preparation et leur application comme medicaments

Country Status (17)

Country Link
US (1) US4171366A (fr)
JP (1) JPS5368776A (fr)
AT (1) AT361469B (fr)
AU (1) AU517512B2 (fr)
BE (1) BE861337A (fr)
CA (1) CA1097351A (fr)
DE (1) DE2753054A1 (fr)
DK (1) DK531977A (fr)
ES (1) ES464611A1 (fr)
FI (1) FI773593A (fr)
FR (1) FR2372829A1 (fr)
GB (1) GB1590648A (fr)
NL (1) NL7713241A (fr)
NO (1) NO146600C (fr)
NZ (1) NZ185824A (fr)
SE (1) SE7713574L (fr)
ZA (1) ZA777129B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8003141A (nl) * 1980-05-30 1982-01-04 Akzo Nv Biologisch aktieve tricyclische aminen.
GB8726505D0 (en) * 1987-11-12 1987-12-16 Ici Plc Naphtho(2 1-b)furan derivatives
JPH0249772A (ja) * 1988-04-07 1990-02-20 Glaxo Group Ltd イミダゾール誘導体
GB9407919D0 (en) * 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds
WO2011049704A1 (fr) * 2009-10-22 2011-04-28 The University Of North Carolina At Chapel Hill Dérivés d'antofine et de cryptopleurine en tant qu'agents anticancéreux

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2300081A1 (fr) * 1975-02-05 1976-09-03 Rohm & Haas Nouveaux d

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903092A (en) * 1966-03-02 1975-09-02 Aspro Nicholas Ltd 2-Tertiaryamino-1-(benzo{8 b{9 thienyl)ethanols

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2300081A1 (fr) * 1975-02-05 1976-09-03 Rohm & Haas Nouveaux d

Also Published As

Publication number Publication date
FI773593A (fi) 1978-06-02
GB1590648A (en) 1981-06-03
US4171366A (en) 1979-10-16
BE861337A (fr) 1978-05-30
AU3108777A (en) 1979-06-07
SE7713574L (sv) 1978-06-02
DE2753054A1 (de) 1978-06-08
AT361469B (de) 1981-03-10
AU517512B2 (en) 1981-08-06
ES464611A1 (es) 1978-09-01
FR2372829B1 (fr) 1982-06-04
NO774101L (no) 1978-06-02
DK531977A (da) 1978-06-02
CA1097351A (fr) 1981-03-10
NL7713241A (fr) 1978-06-05
NO146600B (no) 1982-07-26
ZA777129B (en) 1978-09-27
NO146600C (no) 1982-11-03
ATA857177A (de) 1980-08-15
NZ185824A (en) 1980-08-26
JPS5368776A (en) 1978-06-19

Similar Documents

Publication Publication Date Title
FR2422643A1 (fr) Nouveaux derives d'imidazolidine, leur preparation et leur application comme medicaments
FR2400512A1 (fr) Nouveaux nitro-imidazoles, leur preparation et leur application en tant que medicaments
FR2403340A1 (fr) Derives imidazoliques utiles comme medicaments
FR2422634A1 (fr) Isosteres de type 9-desoxy-9a-methylene de pgi2, utiles comme medicaments, et leur procede de preparation
FR2398748A1 (fr) Nouveaux derives d'imidazoquinazoline, leur preparation et leur application en tant que medicaments
FR2390420A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
FR2377418A1 (fr) Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
FR2426681A1 (fr) Derives d'hydantoine, procede pour leur preparation et application de ces composes comme medicaments
FR2377419A1 (fr) Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2403330A1 (fr) Nouveaux derives de benzoyl-2-chloro-4-glycinanilides substitues, leur procede de preparation et leur application en tant que medicaments
FR2370744A1 (fr) Nouveaux derives d'aminopropanol, procede pour leur preparation et medicaments contenant ces composes
FR2419933A1 (fr) Procede de production de derives de n'-phenyl-n-methyluree, nouveaux produits ainsi obtenus et leur utilisation comme herbicides
FR2398058A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2415636A1 (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
FR2415103A1 (fr) Acides et derives d'acides 4-pyridone-3-carboxyliques, leur preparation et leur application en tant que medicaments
FR2366284A1 (fr) Derives de benzimidazole, leur procede de leur preparation et leur utilisation comme anthelmintiques
FR2355021A1 (fr) Nouveaux derives d'imidazothiazine et leur application en tant que medicaments
FR2370745A1 (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments
FR2372829A1 (fr) Nouveaux derives imidazoliques, leur procede de preparation et leur application comme medicaments
FR2388799A1 (fr) Derives de pyridazinone, leur procede de preparation et leur application comme medicaments
FR2379538A1 (fr) Nouveaux derives d'oxadiazolopyrimidine, leur preparation et leur application en tant que medicaments
FR2387983A1 (fr) Nouveaux derives de benzodiazepine utiles comme medicaments
FR2359154A1 (fr) Derives peptidiques utiles comme medicaments et procede pour leur preparation
FR2419288A1 (fr) Nouveaux derives du 5-fluoruracile, leur procede d'obtention et leur application en tant que medicaments
FR2397391A1 (fr) Alpha-halogenomethyl-phenylalanines et leurs derives, leur preparation et leur utilisation comme medicaments, notamment pour traiter la maladie de parkinson ou un etat de psychose

Legal Events

Date Code Title Description
ST Notification of lapse